Top compounds associated with response to DOK2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-08
mRNA PD318088 CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.22 2e-08
mRNA BIX02189 GDSC1000 pan-cancer AAC 0.19 2e-08
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.21 3e-08
mRNA XL-184 GDSC1000 pan-cancer AAC 0.21 3e-08
mRNA regorafenib CTRPv2 pan-cancer AAC 0.22 6e-08
mRNA quizartinib CTRPv2 pan-cancer AAC 0.21 9e-08
mRNA BMS-270394 CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.19 3e-07
Download CSV